$4.52
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
C4 Therapeutics
CCCCNASDAQ
C4 Therapeutics (CCCC) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestC4 Therapeutics (NASDAQ:CCCC) Stock Quotes, Forecast and News Summary
C4 Therapeutics Stock (NASDAQ: CCCC) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 2.00 / 1.57M |
| Day Range | - - - |
| 52 Wk Range | 1.06 - 11.88 |
| Market Cap | $311.00M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 41 |
| Short Interest | 25.75% |
| Days to Cover | 11.69 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About C4 Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy C4 Therapeutics (CCCC) stock?
You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.
Who are C4 Therapeutics (CCCC) competitors?
Other companies in C4 Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY), Korro Bio (NASDAQ:KRRO) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for C4 Therapeutics (CCCC) stock?
There is no analysis for C4 Therapeutics.
What is the forecast for C4 Therapeutics (CCCC) stock?
C4 Therapeutics has a consensus price target of $15.82.
Current stock price for C4 Therapeutics (CCCC)?
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $4.52 last updated July 2, 2024 at 4:00 PM EDT.
Does C4 Therapeutics (CCCC) pay a dividend?
There are no upcoming dividends for C4 Therapeutics.
When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?
C4 Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is C4 Therapeutics (CCCC) going to split?
There is no upcoming split for C4 Therapeutics.
What sector and industry does C4 Therapeutics (CCCC) operate in?
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.